{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"CervoMed Inc."},"Symbol":{"label":"Symbol","value":"CRVO"},"Address":{"label":"Address","value":"300 EAST MAIN STREET,SUITE 201, CHARLOTTESVILLE, Virginia, 22902, United States"},"Phone":{"label":"Phone","value":"+1 434 220-0718"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer."},"CompanyUrl":{"label":"Company Url","value":"https://www.cervomed.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John J. Alam","title":"President, Chief Executive Officer & Director"},{"name":"Kelly Blackburn","title":"Senior Vice President-Clinical Development"},{"name":"Robert J. Cobuzzi","title":"Chief Operating Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}